FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Beatrice Waser

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Tissue Distribution

Disorders

Living Beings

Physiology

Binding, Competitive

Co-author Network

Publications

TOP 3
Melpomeni Fani; Helmut R Maecke; Jean E Rivier; Beatrice Waser; Wolfgang A Weber; Karin Beetschen; Friederike Braun; Renzo Cescato; Judit Erchegyi; Jean Claude Reubi
Unexpected sensitivity of sst2 antagonists to N-terminal radiometal modifications.
Beatrice Waser; Agnes Schonbrunn; Renzo Cescato; Emanuel Christ; Yachu J Kao; Meike Körner; Qisheng Liu; Jean Claude Reubi
Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients.
Beatrice Waser; Claire Sanchez; Daniel Fourmy; Ruth Rehmann; Jean Claude Reubi
Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Beatrice Waser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Melpomeni Fani; Helmut R Maecke; Jean E Rivier; Beatrice Waser; Wolfgang A Weber; Karin Beetschen; Friederike Braun; Renzo Cescato; Judit Erchegyi; Jean Claude Reubi
Unexpected sensitivity of sst2 antagonists to N-terminal radiometal modifications.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(9):1481-9.
2012: Beatrice Waser; Agnes Schonbrunn; Renzo Cescato; Emanuel Christ; Yachu J Kao; Meike Körner; Qisheng Liu; Jean Claude Reubi
Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients.
The American journal of pathology 2012;180(5):1942-9.
2012: Beatrice Waser; Claire Sanchez; Daniel Fourmy; Ruth Rehmann; Jean Claude Reubi
Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors.
The Journal of clinical endocrinology and metabolism 2012;97(2):482-8.
2012: Hanwen Zhang; Keelara Abiraj; Michael Honer; Jean Claude Reubi; Peter Smith-Jones; Daniel L J Thorek; Beatrice Waser; Helmut R Maecke
Evolution of bombesin conjugates for targeted PET imaging of tumors.
PloS one 2012;7(9):e44046.
2011: Renzo Cescato; Melpomeni Fani; Beatrice Waser; Jean Claude Reubi
Evaluation of 177Lu-DOTA-sst2 antagonist versus 177Lu-DOTA-sst2 agonist binding in human cancers in vitro.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(12):1886-90.
2011: Judit Erchegyi; Jean E Rivier; Beatrice Waser; Renzo Cescato; Jean Claude Reubi
N-imidazolebenzyl-histidine substitution in somatostatin and in its octapeptide analogue modulates receptor selectivity and function.
Journal of medicinal chemistry 2011;54(17):5981-7.
2011: Luigi Aloj; Michela Aurilio; Karin Beetschen; Wouter A P Breeman; Laura D'ambrosio; Erik De Blois; Lieke Joosten; Stuart Koelewijn; Theodosia Maina; Rosalba Mansi; Marleen Melis; Petra Kolenc Peitl; Jean Claude Reubi; Valentina Rinaldi; Jane K Sosabowski; Diego Tesauro; Elisabeth von Guggenberg; Beatrice Waser; Marion De Jong
Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607.
European journal of nuclear medicine and molecular imaging 2011;38(8):1417-25.
2011: Melpomeni Fani; Keelara Abiraj; Renzo Cescato; Luigi Del Pozzo; Rosalba Mansi; Jean Claude Reubi; Maria Luisa Tamma; Beatrice Waser; Wolfgang A Weber; Helmut R Maecke
PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(7):1110-8.
2011: Beatrice Waser; Jean Claude Reubi
Value of the radiolabelled GLP-1 receptor antagonist exendin(9-39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans.
European journal of nuclear medicine and molecular imaging 2011;38(6):1054-8.
2011: Camryn D Allen; Beatrice Waser; Meike Körner; Jean Claude Reubi; Soon Lee; Catherine Rivier
Neuropeptide Y acts within the rat testis to inhibit testosterone secretion.
Neuropeptides 2011;45(1):55-61.
2011: Rosalba Mansi; Xuejuan Wang; Flavio Forrer; Beatrice Waser; Renzo Cescato; Keith Graham; Sandra Borkowski; Jean Claude Reubi; Helmut R Maecke
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours.
European journal of nuclear medicine and molecular imaging 2011;38(1):97-107.
2010: Jean Claude Reubi; A Perren; Ruth Rehmann; Beatrice Waser; Emanuel R Christ; M Callery; A B Goldfine; M E Patti
Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass.
Diabetologia 2010;53(12):2641-5.
2010: Beatrice Waser; Renzo Cescato; Maria-Luisa Tamma; Helmut R Maecke; Jean Claude Reubi
Absence of somatostatin SST(2) receptor internalization in vivo after intravenous SOM230 application in the AR42J animal tumor model.
European journal of pharmacology 2010;644(1-3):257-62.
2010: Jean Claude Reubi; Judit Erchegyi; Renzo Cescato; Beatrice Waser; Jean E Rivier
Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analog.
European journal of nuclear medicine and molecular imaging 2010;37(8):1551-8.
2010: Jean Claude Reubi; Beatrice Waser; Renzo Cescato; Beat Gloor; Christoph Stettler; Emanuel R Christ
Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patients.
The Journal of clinical endocrinology and metabolism 2010;95(5):2343-50.
2010: Renzo Cescato; Kimberly A Loesch; Beatrice Waser; Helmut R Mäcke; Jean E Rivier; Jean Claude Reubi; Agnes Schonbrunn
Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways.
Molecular endocrinology (Baltimore, Md.) 2010;24(1):240-9.
2009: Rosalba Mansi; Xuejuan Wang; Flavio Forrer; Stefan Kneifel; Maria-Luisa Tamma; Beatrice Waser; Renzo Cescato; Jean Claude Reubi; Helmut R Maecke
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(16):5240-9.
2009: Achim Fleischmann; Beatrice Waser; Jean Claude Reubi
High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications.
Endocrine-related cancer 2009;16(2):623-33.
2009: Beatrice Waser; Maria-Luisa Tamma; Renzo Cescato; Helmut R Maecke; Jean Claude Reubi
Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(6):936-41.
2009: Judit Erchegyi; Renzo Cescato; Christy Rani R Grace; Beatrice Waser; Véronique Piccand; Daniel Hoyer; Roland Riek; Jean E Rivier; Jean Claude Reubi
Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analogues.
Journal of medicinal chemistry 2009;52(9):2733-46.
2008: Stephan Good; Martin A Walter; Beatrice Waser; Xuejuan Wang; Jan Müller-Brand; Martin Béhé; Jean Claude Reubi; Helmut R Maecke
Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours.
European journal of nuclear medicine and molecular imaging 2008;35(10):1868-77.
2008: Meike Körner; Beatrice Waser; Jean Claude Reubi
High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5043-9.
2008: Renzo Cescato; Judit Erchegyi; Beatrice Waser; Véronique Piccand; Helmut R Maecke; Jean E Rivier; Jean Claude Reubi
Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting.
Journal of medicinal chemistry 2008;51(13):4030-7.
2008: Mathias Gugger; Richard White; Susan Song; Beatrice Waser; Renzo Cescato; Pierre Rivière; Jean Claude Reubi
GPR87 is an overexpressed G-protein coupled receptor in squamous cell carcinoma of the lung.
Disease markers 2008;24(1):41-50.
2007: Hanwen Zhang; Jochen Schuhmacher; Beatrice Waser; Damian Wild; Michael Eisenhut; Jean Claude Reubi; Helmut R Maecke
DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours.
European journal of nuclear medicine and molecular imaging 2007;34(8):1198-208.
2007: Patricia Antunes; Mihaela Ginj; Hanwen Zhang; Beatrice Waser; R P Baum; Jean Claude Reubi; Helmut R Maecke
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
European journal of nuclear medicine and molecular imaging 2007;34(7):982-93.
2007: Meike Körner; Martin Stöckli; Beatrice Waser; Jean Claude Reubi
GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(5):736-43.
2007: Achim Fleischmann; Beatrice Waser; Jean Claude Reubi
Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2007;29(5):421-33.
2007: Beatrice Waser; Véronique Eltschinger; Karen Linder; Adrian Nunn; Jean Claude Reubi
Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA.
European journal of nuclear medicine and molecular imaging 2007;34(1):95-100.
2006: Damian Wild; Martin Béhé; Andreas Wicki; Daniel Storch; Beatrice Waser; Martin Gotthardt; Boris Keil; Gerhard Christofori; Jean Claude Reubi; Helmut R Mäcke
[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(12):2025-33.
2006: Beatrice Waser; Ruth Rehmann; Jean Rivier; Wylie Vale; Jean Claude Reubi
CRF receptors in the rodent and human cardiovascular systems: species differences.
Peptides 2006;27(12):3029-38.
2006: Mihaela Ginj; Hanwen Zhang; Beatrice Waser; Renzo Cescato; Damian Wild; Xuejuan Wang; Judit Erchegyi; Jean Rivier; Helmut R Mäcke; Jean Claude Reubi
Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(44):16436-41.
2006: Mihaela Ginj; Jörg S Schmitt; Jianhua Chen; Beatrice Waser; Jean Claude Reubi; Marion de Jong; Stefan Schulz; Helmut R Maecke
Design, synthesis, and biological evaluation of somatostatin-based radiopeptides.
Chemistry & biology 2006;13(10):1081-90.
2006: Stefan Kneifel; Dominik Cordier; Stephan Good; Mihai C S Ionescu; Anthony Ghaffari; Silvia Hofer; Martin Kretzschmar; Markus Tolnay; Christos Apostolidis; Beatrice Waser; Marlene Arnold; Jan Mueller-Brand; Helmut R Maecke; Jean Claude Reubi; Adrian Merlo
Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance p.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(12):3843-50.
2006: Adrian Schmassmann; Georg Zoidl; Brigitta M Peskar; Beatrice Waser; Diana Schmassmann-Suhijar; Jan-Olaf Gebbers; Jean Claude Reubi
Role of the different isoforms of cyclooxygenase and nitric oxide synthase during gastric ulcer healing in cyclooxygenase-1 and -2 knockout mice.
American journal of physiology. Gastrointestinal and liver physiology 2006;290(4):G747-56.
2006: Renzo Cescato; Stefan Schulz; Beatrice Waser; Véronique Eltschinger; Jean E Rivier; Hans-Jürgen Wester; Michael Culler; Mihaela Ginj; Qisheng Liu; Agnes Schonbrunn; Jean Claude Reubi
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):502-11.
2005: Meike Körner; Véronique Eltschinger; Beatrice Waser; Agnes Schonbrunn; Jean Claude Reubi
Value of immunohistochemistry for somatostatin receptor subtype sst2A in cancer tissues: lessons from the comparison of anti-sst2A antibodies with somatostatin receptor autoradiography.
The American journal of surgical pathology 2005;29(12):1642-51.
2005: Achim Fleischmann; Beatrice Waser; Jan-Olaf Gebbers; Jean Claude Reubi
Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments.
The Journal of clinical endocrinology and metabolism 2005;90(8):4722-9.
2005: Meike Körner; Beatrice Waser; Jean Claude Reubi
Neuropeptide Y receptors in renal cell carcinomas and nephroblastomas.
International journal of cancer. Journal international du cancer 2005;115(5):734-41.
2005: Damian Wild; Helmut R Mäcke; Beatrice Waser; Jean Claude Reubi; Mihaela Ginj; Helmut Rasch; Jan Müller-Brand; Michael Hofmann
68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.
European journal of nuclear medicine and molecular imaging 2005;32(6):724.
2005: Theodosia Maina; Berthold A Nock; Hanwen Zhang; Anastasia Nikolopoulou; Beatrice Waser; Jean Claude Reubi; Helmut R Maecke
Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(5):823-30.
2005: Jean E Rivier; Dean A Kirby; Judit Erchegyi; Beatrice Waser; Véronique Eltschinger; Renzo Cescato; Jean Claude Reubi
Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides.
Journal of medicinal chemistry 2005;48(2):515-22.
2005: Judit Erchegyi; Carl A Hoeger; William Low; Daniel Hoyer; Beatrice Waser; Véronique Eltschinger; Jean-Claude Schaer; Renzo Cescato; Jean Claude Reubi; Jean E Rivier
Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan.
Journal of medicinal chemistry 2005;48(2):507-14.
2005: Berthold A Nock; Anastasia Nikolopoulou; Athanassios S Galanis; Paul Cordopatis; Beatrice Waser; Jean Claude Reubi; Theodosia Maina
Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.
Journal of medicinal chemistry 2005;48(1):100-10.
2004: Meike Körner; Beatrice Waser; Jean Claude Reubi
High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8426-33.
2004: Mathias Gugger; Beatrice Waser; Andreas Kappeler; Agnes Schonbrunn; Jean Claude Reubi
Cellular detection of sst2A receptors in human gastrointestinal tissue.
Gut 2004;53(10):1431-6.
2004: Hanwen Zhang; Jianhua Chen; Christian Waldherr; Karin Hinni; Beatrice Waser; Jean Claude Reubi; Helmut R Maecke
Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors.
Cancer research 2004;64(18):6707-15.
2004: Jean Claude Reubi; Meike Körner; Beatrice Waser; Luca Mazzucchelli; Louis Guillou
High expression of peptide receptors as a novel target in gastrointestinal stromal tumours.
European journal of nuclear medicine and molecular imaging 2004;31(6):803-10.
2004: Mathias Gugger; Beatrice Waser; Andreas Kappeler; Agnes Schonbrunn; Jean Claude Reubi
Immunohistochemical localization of somatostatin receptor sst2A in human gut and lung tissue: possible implications for physiology and carcinogenesis.
Annals of the New York Academy of Sciences 2004;1014():132-6.
2004: Adrian Schmassmann; Beatrice Waser; Beatrice Flogerzi; Jean Claude Reubi
Expression of functional neurokinin-1 receptors in regenerative glands during gastric wound healing in rodents.
Gastroenterology 2004;126(3):784-95.
2004: Meike Körner; Beatrice Waser; Jean Claude Reubi
Neuropeptide Y receptor expression in human primary ovarian neoplasms.
Laboratory investigation; a journal of technical methods and pathology 2004;84(1):71-80.
2003: Judit Erchegyi; Beatrice Waser; Jean-Claude Schaer; Renzo Cescato; Jean François Brazeau; Jean Rivier; Jean Claude Reubi
Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Journal of medicinal chemistry 2003;46(26):5597-605.
2003: Judit Erchegyi; Botond Penke; Lajos Simon; Scott Michaelson; Sandra Wenger; Beatrice Waser; Renzo Cescato; Jean-Claude Schaer; Jean Claude Reubi; Jean Rivier
Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Journal of medicinal chemistry 2003;46(26):5587-96.
2003: Jean Rivier; Judit Erchegyi; Carl A Hoeger; Charleen Miller; William Low; Sandra Wenger; Beatrice Waser; Jean-Claude Schaer; Jean Claude Reubi
Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Journal of medicinal chemistry 2003;46(26):5579-86.
2003: Jean Claude Reubi; Beatrice Waser; Mathias Gugger; Helmut Friess; Jörg Kleeff; Hany Kayed; Markus W Büchler; Jean A Laissue
Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue.
Gastroenterology 2003;125(1):98-106.
2003: Jean Claude Reubi; Beatrice Waser; Wylie Vale; Jean Rivier
Expression of CRF1 and CRF2 receptors in human cancers.
The Journal of clinical endocrinology and metabolism 2003;88(7):3312-20.
2003: Jean Claude Reubi; Beatrice Waser
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting.
European journal of nuclear medicine and molecular imaging 2003;30(5):781-93.
2002: Jean Claude Reubi; Klaus-Peter Eisenwiener; Hans Rink; Beatrice Waser; Helmut R Mäcke
A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors.
European journal of pharmacology 2002;456(1-3):45-9.
2002: Jean Rivier; Jozsef Gulyas; D Kirby; William Low; Marilyn H Perrin; Koichi S Kunitake; Michael R DiGruccio; Joan Vaughan; Jean Claude Reubi; Beatrice Waser; Steven C Koerber; Vicente Martinez; L Wang; Yvette Taché; Wylie Vale
Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.
Journal of medicinal chemistry 2002;45(21):4737-47.
2002: Claude Reubi; Mathias Gugger; Beatrice Waser
Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting.
European journal of nuclear medicine and molecular imaging 2002;29(7):855-62.
2001: Jean Claude Reubi; Beatrice Waser; Jean-Claude Schaer; Jean A Laissue
Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands.
European journal of nuclear medicine 2001;28(7):836-46.
2001: Jean E Rivier; Carl A Hoeger; Judit Erchegyi; Jozsef Gulyas; R DeBoard; A Grey Craig; Steven C Koerber; Sandra Wenger; Beatrice Waser; Jean-Claude Schaer; Jean Claude Reubi
Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1).
Journal of medicinal chemistry 2001;44(13):2238-46.
2001: Jean Claude Reubi; Mathias Gugger; Beatrice Waser; Jean-Claude Schaer
Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.
Cancer research 2001;61(11):4636-41.
2000: Jean Claude Reubi; Jean-Claude Schaer; Sandra Wenger; Carl A Hoeger; Judit Erchegyi; Beatrice Waser; Jean Rivier
SST3-selective potent peptidic somatostatin receptor antagonists.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(25):13973-8.
2000: Jean Claude Reubi; Beatrice Waser; Qisheng Liu; Jean A Laissue; Agnes Schonbrunn
Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location.
The Journal of clinical endocrinology and metabolism 2000;85(10):3882-91.
2000: Jean Claude Reubi; U Läderach; Beatrice Waser; Jan-Olaf Gebbers; P Robberecht; Jean A Laissue
Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
Cancer research 2000;60(11):3105-12.
2000: Jean Claude Reubi; J C Schär; Beatrice Waser; Sandra Wenger; Axel Heppeler; Jörg S Schmitt; Helmut R Mäcke
Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use.
European journal of nuclear medicine 2000;27(3):273-82.
1999: Jean Claude Reubi; Arthur Zimmermann; S Jonas; Beatrice Waser; P Neuhaus; U Läderach; Bertram Wiedenmann
Regulatory peptide receptors in human hepatocellular carcinomas.
Gut 1999;45(5):766-74.
1999: Jean Claude Reubi; Jean A Laissue; Beatrice Waser; D L Steffen; R William Hipkin; Agnes Schonbrunn
Immunohistochemical detection of somatostatin sst2a receptors in the lymphatic, smooth muscular, and peripheral nervous systems of the human gastrointestinal tract: facts and artifacts.
The Journal of clinical endocrinology and metabolism 1999;84(8):2942-50.
1999: Jean Claude Reubi; Beatrice Waser; Jean-Claude Schaer; Jean A Laissue
Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas.
International journal of cancer. Journal international du cancer 1999;82(2):213-8.
1999: Jean Claude Reubi; Beatrice Waser; Adrian Schmassmann; Jean A Laissue
Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: where are they really located?
International journal of cancer. Journal international du cancer 1999;81(3):376-86.
1998: Jean Claude Reubi; Andreas Kappeler; Beatrice Waser; Agnes Schonbrunn; Jean A Laissue
Immunohistochemical localization of somatostatin receptor sst2A in human pancreatic islets.
The Journal of clinical endocrinology and metabolism 1998;83(10):3746-9.
1998: Jean Claude Reubi; Andreas Kappeler; Beatrice Waser; Jean A Laissue; R William Hipkin; Agnes Schonbrunn
Immunohistochemical localization of somatostatin receptors sst2A in human tumors.
The American journal of pathology 1998;153(1):233-45.
1998: Jean Claude Reubi; Beatrice Waser; Jean-Claude Schaer; U Laederach; Jack Erion; Ananth Srinivasan; Michelle A Schmidt; Joseph E Bugaj
Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo.
European journal of nuclear medicine 1998;25(5):481-90.
1998: Jean Claude Reubi; Beatrice Waser; Helmut Friess; Markus W Büchler; Jean A Laissue
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
Gut 1998;42(4):546-50.
1998: Jean Claude Reubi; Jean-Claude Schaer; Beatrice Waser; Carl A Hoeger; Jean Rivier
A selective analog for the somatostatin sst1-receptor subtype expressed by human tumors.
European journal of pharmacology 1998;345(1):103-10.
1997: Jean Claude Reubi; Jean-Claude Schaer; Regula Markwalder; Beatrice Waser; U Horisberger; Jean A Laissue
Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance.
The Yale journal of biology and medicine 1997;70(5-6):471-9.
1997: Jean Claude Reubi; Jean-Claude Schaer; Beatrice Waser
Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Cancer research 1997;57(7):1377-86.
1997: Jean Claude Reubi; Beatrice Waser; U Läderach; Christoph Stettler; Helmut Friess; Fred Halter; Adrian Schmassmann
Localization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach.
Gastroenterology 1997;112(4):1197-205.
1997: Jean-Claude Schaer; Beatrice Waser; G Mengod; Jean Claude Reubi
Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography.
International journal of cancer. Journal international du cancer 1997;70(5):530-7.
1996: P Martin van Hagen; Wouter A P Breeman; J C Reubi; P T Postema; P J van den Anker-Lugtenburg; Dik J Kwekkeboom; Jean A Laissue; Beatrice Waser; Steven W J Lamberts; Theo J Visser; Eric P Krenning
Visualization of the thymus by substance P receptor scintigraphy in man.
European journal of nuclear medicine 1996;23(11):1508-13.
1996: Jean Claude Reubi; Beatrice Waser
Unexpected high incidence of cholecystokinin-B/gastrin receptors in human medullary thyroid carcinomas.
International journal of cancer. Journal international du cancer 1996;67(5):644-7.
1996: Jean Claude Reubi; Jean-Claude Schaer; Jean A Laissue; Beatrice Waser
Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels.
Metabolism: clinical and experimental 1996;45(8 Suppl 1):39-41.
1996: Jean Claude Reubi; Beatrice Waser; Jean A Laissue; J O Gebbers
Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.
Cancer research 1996;56(8):1922-31.
1996: M John; Wolfgang Meyerhof; D Richter; Beatrice Waser; Jean-Claude Schaer; Hans Scherübl; J Boese-Landgraf; Peter Neuhaus; C Ziske; K Mölling; Ernst-Otto Riecken; Jean Claude Reubi; Bertram Wiedenmann
Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.
Gut 1996;38(1):33-9.
1995: Jean Claude Reubi; Beatrice Waser; Jean-Claude Schaer; Regula Markwalder
Somatostatin receptors in human prostate and prostate cancer.
The Journal of clinical endocrinology and metabolism 1995;80(9):2806-14.
1994: Jean Claude Reubi; Beatrice Waser; H M Markusse; E P Krenning; M VanHagen; Jean A Laissue
Vascular somatostatin receptors in synovium from patients with rheumatoid arthritis.
European journal of pharmacology 1994;271(2-3):371-8.
1994: Jean Claude Reubi; Jean A Laissue; Beatrice Waser; U Horisberger; Jean-Claude Schaer
Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues.
Annals of the New York Academy of Sciences 1994;733():122-37.
1994: Jean Claude Reubi; Beatrice Waser; Adrian Schmassmann; Fred Halter
Persistent lack of somatostatin receptors in gastric mucosa of healing ulcers in rats.
Gastroenterology 1994;107(2):339-46.
1994: Jean Claude Reubi; Jean-Claude Schaer; Beatrice Waser; G Mengod
Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
Cancer research 1994;54(13):3455-9.
1993: Jean Claude Reubi; U Horisberger; U E Studer; Beatrice Waser; Jean A Laissue
Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta.
The Journal of clinical endocrinology and metabolism 1993;77(5):1323-8.
1993: Jean Claude Reubi; Beatrice Waser; U Horisberger; E Krenning; Steven W J Lamberts; J O Gebbers; P Gersbach; Jean A Laissue
In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue.
Blood 1993;82(7):2143-51.
1993: A H Bootsma; C H J van Eijck; K K Schouten; J C Reubi; Beatrice Waser; John A Foekens; R van Pel; Ellen C Zwarthoff; Steven W J Lamberts; Annelies de Klein
Somatostatin receptor-positive primary breast tumors: genetic, patient and tumor characteristics.
International journal of cancer. Journal international du cancer 1993;54(3):357-62.
1993: Jean Claude Reubi; Beatrice Waser; Steven W J Lamberts; G Mengod
Somatostatin (SRIH) messenger ribonucleic acid expression in human neuroendocrine and brain tumors using in situ hybridization histochemistry: comparison with SRIH receptor content.
The Journal of clinical endocrinology and metabolism 1993;76(3):642-7.
1992: Jean Claude Reubi; U Horisberger; Beatrice Waser; J O Gebbers; Jean A Laissue
Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue.
Gastroenterology 1992;103(4):1207-14.
1992: Jean Claude Reubi; Beatrice Waser; U Horisberger; F Halter; Carol J Soroka; R R Kumar; James R Goldenring; Irvin M Modlin
Identification of somatostatin and gastrin receptors on enterochromaffin-like cells from Mastomys gastric tumors.
Endocrinology 1992;131(1):166-72.
1992: J C Reubi; Beatrice Waser; S Khosla; L Kvols; J R Goellner; E Krenning; S Lamberts
In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas.
The Journal of clinical endocrinology and metabolism 1992;74(5):1082-9.
1992: Jean Claude Reubi; Beatrice Waser; M van Hagen; Steven W J Lamberts; E P Krenning; J O Gebbers; Jean Laissue
In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.
International journal of cancer. Journal international du cancer 1992;50(6):895-900.
1990: J C Reubi; Beatrice Waser; J A Foekens; J G Klijn; S W Lamberts; Jean A Laissue
Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors.
International journal of cancer. Journal international du cancer 1990;46(3):416-20.
1990: J C Reubi; Beatrice Waser; M Sheppard; V Macaulay
Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors.
International journal of cancer. Journal international du cancer 1990;45(2):269-74.